Ajay Madan - Chief Development Officer at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Issuer Symbol
CRNX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ajay Madan since 02 Feb 2025

Holdings reported by Ajay Madan for Crinetics Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 176,995 $6,663,862 $37.65 01 Mar 2022 Direct
Common Stock (right to buy) 65,400 $1,442,724 $22.06 28 Feb 2022 Direct Common Stock
Stock Option (right to buy) 0 28 Oct 2021 Direct Common Stock

Transactions reported by Ajay Madan for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.